🎁 Black Friday: up to 50% off of annual plans
Maxigen Biotech Inc. (TPE:1783)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.80
-2.00 (-5.92%)
Nov 20, 2026, 1:30 PM CST

Maxigen Biotech Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
856.96811.56680.65622.12604.43511.98
856.96811.56680.65622.12604.43511.98
Revenue Growth
8.13%19.23%9.41%2.93%18.06%11.86%
Cost of Revenue
248.12247.84197.33198.02230.44250.95
Gross Profit
608.85563.72483.33424.09373.99261.03
Selling, General & Admin
169.03183.89176.98205.45141.0392.38
Research & Development
159.73126.11111.9768.699.6375.68
Operating Expenses
327.48302.68303.42274.24245.38171.08
Operating Income
281.37261.04179.91149.85128.6289.95
Interest Expense
-0.31-0.04---0.07-0.2
Interest & Investment Income
37.835.2827.4325.023.180.48
Currency Exchange Gain (Loss)
3.833.8317.14431.69-3.6
Other Non Operating Income (Expenses)
9.384.781.050.661.0810.84
EBT Excluding Unusual Items
332.08304.89225.53179.53164.597.47
Gain (Loss) on Sale of Investments
--0.02---
Gain (Loss) on Sale of Assets
---013.621.03-
Other Unusual Items
----0.26-
Pretax Income
332.08304.89225.55193.14165.7897.47
Income Tax Expense
29.0739.5835.3827.3126.389.8
Net Income
303.01265.31190.17165.83139.487.67
Net Income to Common
303.01265.31190.17165.83139.487.67
Net Income Growth
29.45%39.52%14.68%18.95%59.01%38.47%
Shares Outstanding (Basic)
909089898984
Shares Outstanding (Diluted)
919090898985
Shares Change
0.39%0.77%0.27%0.07%5.78%4.81%
EPS (Basic)
3.382.962.131.861.571.04
EPS (Diluted)
3.352.942.121.851.561.04
EPS Growth
29.32%38.68%14.59%18.59%50.28%31.75%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
224.56208.36266.45148.76254.05103.34
Free Cash Flow Per Share
2.482.312.971.662.841.22
Dividend Per Share
2.0002.0000.8301.0000.476-
Dividend Growth
140.96%140.96%-17.00%110.00%-24.65%-
Gross Margin
71.05%69.46%71.01%68.17%61.88%50.98%
Operating Margin
32.83%32.16%26.43%24.09%21.28%17.57%
Profit Margin
35.36%32.69%27.94%26.66%23.06%17.12%
Free Cash Flow Margin
26.21%25.67%39.15%23.91%42.03%20.18%
EBITDA
319.98293.07206.75177.09156.71119.73
EBITDA Margin
37.34%36.11%30.38%28.47%25.93%23.39%
D&A For EBITDA
38.6132.0326.8527.2428.0929.79
EBIT
281.37261.04179.91149.85128.6289.95
EBIT Margin
32.83%32.16%26.43%24.09%21.28%17.57%
Effective Tax Rate
8.75%12.98%15.69%14.14%15.91%10.05%